Stefania Bartolini

<i>MGMT</i> Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients

Alba A. Brandes, Enrico Franceschi, Alicia Tosoni et al. · Journal of Clinical Oncology · 2008 · 819 citations · Full text

Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non-Small-Cell Lung Cancer

Federico Cappuzzo, Elisabetta Magrini, Giovanni Luca Ceresoli et al. · JNCI Journal of the National Cancer Institute · 2004 · 367 citations · Full text

Increased<i>HER2</i>Gene Copy Number Is Associated With Response to Gefitinib Therapy in Epidermal Growth Factor Receptor–Positive Non–Small-Cell Lung Cancer Patients

Federico Cappuzzo, Marileila Varella‐Garcia, Hisayuki Shigematsu et al. · Journal of Clinical Oncology · 2005 · 366 citations · Full text

Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial

Giovanni Luca Ceresoli, Federico Cappuzzo, Vanesa Gregorc et al. · Annals of Oncology · 2004 · 352 citations · Full text

Non-small-cell Lung Cancer, Brain Metastases, Medicine +7

Gefitinib in Pretreated Non–Small-Cell Lung Cancer (NSCLC): Analysis of Efficacy and Correlation With HER2 and Epidermal Growth Factor Receptor Expression in Locally Advanced or Metastatic NSCLC

Federico Cappuzzo, Vanesa Gregorc, Elisa Rossi et al. · Journal of Clinical Oncology · 2003 · 213 citations